Series A - Abridge

Series A - Abridge

Investment Firm

Overview

Abridge is a medical conversation AI startup that structures and summarizes medical conversations for doctors and patients.

Announced Date

Oct 06, 2020

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Union Square Ventures

Union Square Ventures

Union Square Ventures is a early_stage_venture and late_stage_venture and seed and venture firm.

UPMC

UPMC

No designation

Participant Investors

8

Investor Name
Participant InvestorPillar VC
Participant InvestorUnion Square Ventures
Participant InvestorEsther Dyson
Participant InvestorBessemer Venture Partners
Participant InvestorANEESH P. CHOPRA

Round Details and Background

Abridge raised $10000000 on 2020-10-06 in Series A

Abridge is a medical conversation AI startup that structures and summarizes medical conversations for doctors and patients.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 11, 2022
Series A - Abridge
7-12.5M
May 18, 2023
Corporate Round - Abridge
1-undefined
Oct 26, 2023
Series B - Abridge
9-30.0M
Feb 23, 2024
Series C - Abridge
10-150.0M

Recent Activity

There is no recent news or activity for this profile.